The Lancet2d
A step towards more physiological glucocorticoid dosing in congenital adrenal hyperplasia
On Dec 12, 2024, the US Food and Drug Administration (FDA) approved crinecerfont for adults and paediatric patients with ...
Healthline3d
Neonatal Adrenoleukodystrophy (NALD) and Zellweger Spectrum Disorder (ZSD)
Treatment typically involves supportive care to reduce the effect of the symptoms. Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic research institutions ...
Medscape3d
APA Guideline for Treating Adults With Schizophrenia
In April, the American Psychiatric Association (APA) released a comprehensive treatment guideline for treating adults who have been diagnosed with schizophrenia. Titled "The Practice Guideline for ...
Medscape6d
Thyroid Disease During Pregnancy
Adverse pregnancy and neonatal outcomes are increased by maternal thyroid disease and adequate treatment is thought to reduce these risks. Hypothyroidism is commonly treated with levothyroxine ...
National Institute for Health and Care Excellence4d
Published guidance, NICE advice and quality standards
diagnosis and treatment CG81 23 February 2009 19 February 2025 Ganaxolone for treating seizures caused by CDKL5 deficiency disorder in people 2 years and over TA1033 12 February 2025 12 February 2025 ...
ahajournals.org5d
Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association
The evidence supporting the efficacy of exercise therapy for patients with PAD dates back to 1966 when 6 months of unsupervised intermittent walking exercise was demonstrated to improve time walked to ...